FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000253156> ?p ?o ?g. }

• W2000253156 endingPage "25" @default.
• W2000253156 startingPage "17" @default.
• W2000253156 abstract "To investigate the duration of remission and low disease activity (LDA) after cessation of tocilizumab (TCZ) treatment in rheumatoid arthritis patients who showed remission or LDA as assessed by DAS28 in response to preceding TCZ monotherapy, and to explore the factors contributing to prolonged efficacy duration.Disease activity was monitored for 56 weeks. The rate of continued efficacy was estimated by Kaplan-Meier curves.A total of 187 patients were eligible. At baseline of this study, median disease duration was 7.8 years, preceding TCZ treatment period was 4.0 years and DAS28 was 1.5. The rate of continued LDA at 52 weeks was 13.4 % according to the Kaplan-Meier estimate. 19 patients (10 %) were completely drug-free and 17 patients (9.1 %) fulfilled DAS28 remission at 52 weeks. Multivariate Cox regression analysis identified low serum IL-6 and normalisation of MMP-3 levels at cessation of TCZ as independent predictive markers for longer duration of LDA. In patients with low serum IL-6 (<12.9 pg/mL) and normal MMP-3 levels, the rate of continued LDA reached 38.0 % at 52 weeks.TCZ monotherapy may induce biologics-free remission or LDA without concomitant use of synthetic DMARDs. Serum levels of IL-6 and MMP-3 are useful markers for identifying patients who could discontinue TCZ without acute disease flare." @default.
• W2000253156 created "2016-06-24" @default.
• W2000253156 creator A5000556430 @default.
• W2000253156 creator A5006569868 @default.
• W2000253156 creator A5006840017 @default.
• W2000253156 creator A5009246406 @default.
• W2000253156 creator A5013526431 @default.
• W2000253156 creator A5019331714 @default.
• W2000253156 creator A5027659079 @default.
• W2000253156 creator A5028034286 @default.
• W2000253156 creator A5030740263 @default.
• W2000253156 creator A5032838648 @default.
• W2000253156 creator A5039553170 @default.
• W2000253156 creator A5041976581 @default.
• W2000253156 creator A5042340344 @default.
• W2000253156 creator A5053192443 @default.
• W2000253156 creator A5063350161 @default.
• W2000253156 creator A5064587822 @default.
• W2000253156 creator A5069643339 @default.
• W2000253156 creator A5071921056 @default.
• W2000253156 creator A5080767944 @default.
• W2000253156 creator A5082674163 @default.
• W2000253156 creator A5083314956 @default.
• W2000253156 creator A5086977819 @default.
• W2000253156 creator A5087307078 @default.
• W2000253156 creator A5090428843 @default.
• W2000253156 creator A5090740323 @default.
• W2000253156 creator A5091412522 @default.
• W2000253156 date "2013-11-22" @default.
• W2000253156 modified "2023-10-02" @default.
• W2000253156 title "Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study" @default.
• W2000253156 cites W2022713850 @default.
• W2000253156 cites W2023761225 @default.
• W2000253156 cites W2054059257 @default.
• W2000253156 cites W2062697678 @default.
• W2000253156 cites W2099321660 @default.
• W2000253156 cites W2114308202 @default.
• W2000253156 cites W2125212735 @default.
• W2000253156 cites W2134171514 @default.
• W2000253156 cites W2139339400 @default.
• W2000253156 cites W2152553239 @default.
• W2000253156 cites W4253469911 @default.
• W2000253156 doi "https://doi.org/10.3109/14397595.2013.854079" @default.
• W2000253156 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24261754" @default.
• W2000253156 hasPublicationYear "2013" @default.
• W2000253156 type Work @default.
• W2000253156 sameAs 2000253156 @default.
• W2000253156 citedByCount "104" @default.
• W2000253156 countsByYear W20002531562013 @default.
• W2000253156 countsByYear W20002531562014 @default.
• W2000253156 countsByYear W20002531562015 @default.
• W2000253156 countsByYear W20002531562016 @default.
• W2000253156 countsByYear W20002531562017 @default.
• W2000253156 countsByYear W20002531562018 @default.
• W2000253156 countsByYear W20002531562019 @default.
• W2000253156 countsByYear W20002531562020 @default.
• W2000253156 countsByYear W20002531562021 @default.
• W2000253156 countsByYear W20002531562022 @default.
• W2000253156 countsByYear W20002531562023 @default.
• W2000253156 crossrefType "journal-article" @default.
• W2000253156 hasAuthorship W2000253156A5000556430 @default.
• W2000253156 hasAuthorship W2000253156A5006569868 @default.
• W2000253156 hasAuthorship W2000253156A5006840017 @default.
• W2000253156 hasAuthorship W2000253156A5009246406 @default.
• W2000253156 hasAuthorship W2000253156A5013526431 @default.
• W2000253156 hasAuthorship W2000253156A5019331714 @default.
• W2000253156 hasAuthorship W2000253156A5027659079 @default.
• W2000253156 hasAuthorship W2000253156A5028034286 @default.
• W2000253156 hasAuthorship W2000253156A5030740263 @default.
• W2000253156 hasAuthorship W2000253156A5032838648 @default.
• W2000253156 hasAuthorship W2000253156A5039553170 @default.
• W2000253156 hasAuthorship W2000253156A5041976581 @default.
• W2000253156 hasAuthorship W2000253156A5042340344 @default.
• W2000253156 hasAuthorship W2000253156A5053192443 @default.
• W2000253156 hasAuthorship W2000253156A5063350161 @default.
• W2000253156 hasAuthorship W2000253156A5064587822 @default.
• W2000253156 hasAuthorship W2000253156A5069643339 @default.
• W2000253156 hasAuthorship W2000253156A5071921056 @default.
• W2000253156 hasAuthorship W2000253156A5080767944 @default.
• W2000253156 hasAuthorship W2000253156A5082674163 @default.
• W2000253156 hasAuthorship W2000253156A5083314956 @default.
• W2000253156 hasAuthorship W2000253156A5086977819 @default.
• W2000253156 hasAuthorship W2000253156A5087307078 @default.
• W2000253156 hasAuthorship W2000253156A5090428843 @default.
• W2000253156 hasAuthorship W2000253156A5090740323 @default.
• W2000253156 hasAuthorship W2000253156A5091412522 @default.
• W2000253156 hasConcept C126322002 @default.
• W2000253156 hasConcept C2777178219 @default.
• W2000253156 hasConcept C2777575956 @default.
• W2000253156 hasConcept C2779384505 @default.
• W2000253156 hasConcept C50382708 @default.
• W2000253156 hasConcept C71924100 @default.
• W2000253156 hasConcept C90924648 @default.
• W2000253156 hasConceptScore W2000253156C126322002 @default.
• W2000253156 hasConceptScore W2000253156C2777178219 @default.
• W2000253156 hasConceptScore W2000253156C2777575956 @default.
• W2000253156 hasConceptScore W2000253156C2779384505 @default.
• W2000253156 hasConceptScore W2000253156C50382708 @default.

• next